Opportunities
Sign In/Sign UpMississippi consistently ranks among the unhealthiest states in the U.S., particularly concerning chronic diseases. Despite these challenges, Mississippi has made strides in certain health areas. The state has seen a decline in opioid overdose deaths, and Mississippi continues to lead the nation in childhood vaccination rates. While some progress has been made, much more work needs to be done. Therefore, the MCCTR will support 2-year developmental projects on C&T, community-engaged, and population health research on major chronic diseases impacting Mississippians. Key considerations in awarding support to project investigators will be (1) the scientific rigor of the application, (2) the likelihood of attracting extramural funding, and (3) the probability that the research program would lead to improved health outcomes. All applications selected by the MCCTR for funding require final approval from the NIGMS, and those approved and funded projects will be subject to all current NIH and NIGMS regulatory requirements. The center is funded by the IDeA Program Infrastructure for Clinical and Translational Research grant through the National Institute of General Medical Sciences under the award number 2P50GM115428.
Mississippi consistently ranks among the unhealthiest states in the U.S., particularly concerning chronic diseases. Despite these challenges, Mississippi has made strides in certain areas of health. The state has seen a decline in opioid overdose deaths, and Mississippi continues to lead the nation in childhood vaccination rates. While some progress has been made, much more work needs to be done. Therefore, the MCCTR will support 1-year pilot projects on C&T, community-engaged, and population health research on major chronic diseases impacting Mississippians. Key considerations in awarding support to project investigators will be (1) the scientific rigor of the application, (2) the likelihood of attracting extramural funding, (3) evidence of a path toward an independent research career for the applicant, and (4) the probability that the research program would lead to improved health outcomes. All applications selected by the MCCTR for funding require final approval from the NIGMS, and those approved and funded projects will be subject to all current NIH and NIGMS regulatory requirements. The MCCTR is funded by the IDeA Program Infrastructure for Clinical and Translational Research grant through the National Institute of General Medical Sciences under the award number 2P50GM115428.
Mississippi consistently ranks among the unhealthiest states in the U.S., particularly concerning chronic diseases. Therefore, the MCCTR's primary focus is to leverage an integrated clinical and translational research program across network partner institutions to address major chronic diseases affecting Mississippians. One of the goals that will contribute to this focus is to provide services, free of charge, to network investigators to support the development and execution of innovative research proposals that will lead to a deeper understanding and implementation plans to improve the prevention, diagnosis, and treatment of chronic diseases. The MCCTR Voucher Program provides a structured and efficient mechanism for network investigators to request support services for their research projects. Network investigators include full-time employees (including postdoctoral and clinical fellows) with a strong commitment to C/T research at one of the five MCCTR partner institutions: Mississippi State University, Tougaloo College, University of Mississippi, University of Mississippi Medical Center, and University of Southern Mississippi. The MCCTR is funded by the IDeA Program Infrastructure for Clinical and Translational Research grant through the National Institute of General Medical Sciences under the award number 2P50GM115428.
